# Clinical Trial To Evaluate The Effect Of Valsartan On Insulin Sensitivity In Subjects With Impaired Glucose Tolerance

> **NCT00241072** · PHASE4 · COMPLETED · sponsor: **Novartis** · enrollment: 27 (actual)

## Conditions studied

- Hypertension
- Impaired Glucose Tolerance

## Interventions

- **DRUG:** valsartan

## Key facts

- **NCT ID:** NCT00241072
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-09
- **Primary completion:** 2005-07
- **Final completion:** 2005-07
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2012-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00241072

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00241072, "Clinical Trial To Evaluate The Effect Of Valsartan On Insulin Sensitivity In Subjects With Impaired Glucose Tolerance". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00241072. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*